Sylvie Euvrard

Summary

Affiliation: Clinique du Parc Monceau
Country: France

Publications

  1. ncbi request reprint Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma
    Sylvie Euvrard
    Department of Dermatology, Edouard Herriot Hospital, Lyon, France
    Transplantation 81:1093-100. 2006
  2. doi request reprint Sirolimus and secondary skin-cancer prevention in kidney transplantation
    Sylvie Euvrard
    Department of Dermatology, Hospices Civils de Lyon, Edouard Herriot Hospital Group, Lyon, France
    N Engl J Med 367:329-39. 2012
  3. ncbi request reprint Immunosuppressants and skin cancer in transplant patients: focus on rapamycin
    Sylvie Euvrard
    Department of Dermatology, Edouard Herriott Hospital, Lyon, France
    Dermatol Surg 30:628-33. 2004
  4. ncbi request reprint Skin cancers following pediatric organ transplantation
    Sylvie Euvrard
    Dermatology Department, Hopital Edouard Herriott, Lyon, France
    Dermatol Surg 30:616-21. 2004
  5. doi request reprint [Skin cancers after organ transplants]
    Sylvie Euvrard
    Service de Dermatologie, Hopital Edouard Herriot, F 69437 Lyon Cedex 03, France
    Presse Med 37:1475-9. 2008
  6. ncbi request reprint Skin cancers after organ transplantation
    Sylvie Euvrard
    Department of Dermatology, Edouard Herriot Hospital, Lyons, France
    N Engl J Med 348:1681-91. 2003
  7. ncbi request reprint [Cutaneous tumors in organ transplant recipients]
    Sylvie Euvrard
    Service de Dermatologie, Hopital Edouard Herriot, place d Arsonval 69437 Lyon
    Presse Med 31:1895-903. 2002
  8. ncbi request reprint Skin cancers after liver transplantation: what to do?
    Sylvie Euvrard
    Department of Dermatology, Edouard Herriot Hospital Pav R, 5 Place d Arsonval, 69437 Lyon Cedex 03, France
    J Hepatol 44:27-32. 2006
  9. ncbi request reprint Conversion from calcineurin inhibitors to sirolimus reduces vascularization and thickness of post-transplant cutaneous squamous cell carcinomas
    Anne Laure Rival-Tringali
    Hospices Civils de Lyon, Hospital Edouard Herriot, Clinique Dermatologique Pav R, 69437 Lyon Cedex 03, France
    Anticancer Res 29:1927-32. 2009
  10. doi request reprint Squamous cell carcinomas are associated with verrucokeratotic cutaneous lesions but not with common warts in organ-transplant patients. A case-control study
    Pascal Joly
    Department of Dermatology, Rouen University Hospital, University of Rouen, Rouen, France
    Transplantation 89:1224-30. 2010

Collaborators

Detail Information

Publications35

  1. ncbi request reprint Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma
    Sylvie Euvrard
    Department of Dermatology, Edouard Herriot Hospital, Lyon, France
    Transplantation 81:1093-100. 2006
    ..The aim of this study was to compare the individual rate of subsequent skin cancers in kidney (KTR) and heart transplant recipients (HTR) after the first squamous cell carcinoma (SCC) and to assess risk factors for tumor multiplicity...
  2. doi request reprint Sirolimus and secondary skin-cancer prevention in kidney transplantation
    Sylvie Euvrard
    Department of Dermatology, Hospices Civils de Lyon, Edouard Herriot Hospital Group, Lyon, France
    N Engl J Med 367:329-39. 2012
    ..Transplant recipients in whom cutaneous squamous-cell carcinomas develop are at high risk for multiple subsequent skin cancers. Whether sirolimus is useful in the prevention of secondary skin cancer has not been assessed...
  3. ncbi request reprint Immunosuppressants and skin cancer in transplant patients: focus on rapamycin
    Sylvie Euvrard
    Department of Dermatology, Edouard Herriott Hospital, Lyon, France
    Dermatol Surg 30:628-33. 2004
    ..Discerning the role of each drug is complicated owing to the fact that most patients generally have combinations of several medications...
  4. ncbi request reprint Skin cancers following pediatric organ transplantation
    Sylvie Euvrard
    Dermatology Department, Hopital Edouard Herriott, Lyon, France
    Dermatol Surg 30:616-21. 2004
    ..Although several studies have been devoted to adult transplant patients, few data are available on the long-term skin malignancies following pediatric organ transplantation...
  5. doi request reprint [Skin cancers after organ transplants]
    Sylvie Euvrard
    Service de Dermatologie, Hopital Edouard Herriot, F 69437 Lyon Cedex 03, France
    Presse Med 37:1475-9. 2008
    ..Primary prevention requires that patients be educated about strict sun protection from the transplant onwards and have a routine annual dermatologic examination enabling early treatment of lesions...
  6. ncbi request reprint Skin cancers after organ transplantation
    Sylvie Euvrard
    Department of Dermatology, Edouard Herriot Hospital, Lyons, France
    N Engl J Med 348:1681-91. 2003
  7. ncbi request reprint [Cutaneous tumors in organ transplant recipients]
    Sylvie Euvrard
    Service de Dermatologie, Hopital Edouard Herriot, place d Arsonval 69437 Lyon
    Presse Med 31:1895-903. 2002
    ..The factors enhancing Kaposi's sarcoma associated with the HHV8 virus remain to be defined. The possibility of transmission of the infection through the graft must lead to the systematic search for this virus in the donors...
  8. ncbi request reprint Skin cancers after liver transplantation: what to do?
    Sylvie Euvrard
    Department of Dermatology, Edouard Herriot Hospital Pav R, 5 Place d Arsonval, 69437 Lyon Cedex 03, France
    J Hepatol 44:27-32. 2006
  9. ncbi request reprint Conversion from calcineurin inhibitors to sirolimus reduces vascularization and thickness of post-transplant cutaneous squamous cell carcinomas
    Anne Laure Rival-Tringali
    Hospices Civils de Lyon, Hospital Edouard Herriot, Clinique Dermatologique Pav R, 69437 Lyon Cedex 03, France
    Anticancer Res 29:1927-32. 2009
    ..An investigation was undertaken into the effects of SRL on squamous cell carcinoma (SCC) developing in organ transplant recipients (OTR) receiving immunosuppressive treatments, with special emphasis on vascularization...
  10. doi request reprint Squamous cell carcinomas are associated with verrucokeratotic cutaneous lesions but not with common warts in organ-transplant patients. A case-control study
    Pascal Joly
    Department of Dermatology, Rouen University Hospital, University of Rouen, Rouen, France
    Transplantation 89:1224-30. 2010
    ..Warts are thought to be associated with the development of squamous cell carcinoma (SCC) in organ transplant patients. We investigated the association between the different types of warts and SCC in organ transplant patients...
  11. ncbi request reprint Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 cases
    Jean Kanitakis
    Department of Dermatology, Edouard Herriot Hospital, Lyon, France
    Arch Dermatol 139:1133-7. 2003
    ..To assess the clinicopathologic features of basal cell carcinomas developing in organ transplant recipients...
  12. ncbi request reprint Trichilemmal carcinoma of the skin mimicking a keloid in a heart transplant recipient
    Jean Kanitakis
    Department of Dermatology, Ed Herriot Hospital, Lyon, France
    J Heart Lung Transplant 26:649-51. 2007
    ..We describe the first case of trichilemmal carcinoma presenting with a misleading clinical aspect in a heart transplant recipient. We then briefly outline the salient clinicopathologic features of this malignancy...
  13. doi request reprint Rapidly growing orf in a renal transplant recipient: favourable outcome with reduction of immunosuppression and imiquimod
    Daniela Zaharia
    Department of Dermatology, Edouard Herriot Hospital Group, Hospices Civils de Lyon, Lyon, France
    Transpl Int 23:e62-4. 2010
    ..This case suggests that a rapidly growing orf in transplant patients behaves as an opportunistic infection and therefore minimization should be considered along with a topical treatment...
  14. ncbi request reprint Bowen's Disease masquerading clinically as a follicular cyst in a renal transplant recipient
    Jean Kanitakis
    Department of Dermatology, Ed Herriot Hospital, Lyon, France
    Am J Dermatopathol 29:412-3. 2007
    ..We speculate that this lesion developed from pre-existing Bowen's disease extending to the hair follicles...
  15. ncbi request reprint Differential expression of p-mTOR in cutaneous basal and squamous cell carcinomas likely explains their different response to mTOR inhibitors in organ-transplant recipients
    Georgia Karayannopoulou
    Department of Dermatology, Ed Herriot Hospital Pav R, 69437 Lyon cx 03, France
    Anticancer Res 33:3711-4. 2013
    ..Aim: To investigate if the different response of SCC and BCC to mTOR inhibitors can be explained by differential expression of molecules involved in the mTOR signaling pathway...
  16. doi request reprint Cutaneous cryptococcosis in solid organ transplant recipients: epidemiological, clinical, diagnostic and therapeutic features
    Doriane Biancheri
    Department of Dermatology, Edouard Herriot Hospital Group, Lyon, France
    Eur J Dermatol 22:651-7. 2012
    ..Evidence of dissemination is difficult because of the poor sensitivity of diagnostic tests. Fluconazole was the treatment of choice in association with immunosuppressive treatment tapering...
  17. doi request reprint Basosquamous cell carcinoma in organ transplant patients: a clinicopathologic study
    Fanny Mougel
    Department of Dermatology, Edouard Herriot Hospital Group, Lyon, France
    J Am Acad Dermatol 66:e151-7. 2012
    ..Basosquamous cell carcinoma (BSCC) is a poorly known tumor showing pathological features of both basal and squamous cell carcinomas. BSCC has never been specifically studied in organ transplant recipients (OTRs)...
  18. ncbi request reprint No recurrence of posttransplantation Kaposi's sarcoma three years after renal retransplantation
    Sylvie Euvrard
    Department of Dermatology, Ed Herriot Hospital, Lyon, France
    Transplantation 73:297-9. 2002
    ..This unique observation suggests that retransplantation of patients with previous posttransplantation KS is possible...
  19. ncbi request reprint TP53 polymorphism of exon 4 at codon 72 in cutaneous squamous cell carcinoma and benign epithelial lesions of renal transplant recipients and immunocompetent individuals: lack of correlation with human papillomavirus status
    Sandrine Cairey-Remonnay
    Department of Cell Biology, IETG EA 2085, Besancon, Department of Dermatology, Department of Pathology, and Department of Statistics, Besancon, Department of Dermatology, Lyon, France
    J Invest Dermatol 118:1026-31. 2002
    ..No association between TP53 arginine/arginine genotype and human papillomavirus status could be determined, however...
  20. doi request reprint BRAF mutations in melanocytic tumors (nevi and melanomas) from organ transplant recipients
    Jean Kanitakis
    Department of Dermatology Laboratory of Dermatopathology, Ed Herriot Hospital, 69437 Lyon Cedex 03, France
    Eur J Dermatol 20:167-71. 2010
    ....
  21. doi request reprint Malignancy incidence after renal transplantation in children: a 20-year single-centre experience
    Foteini Koukourgianni
    Centre de Référence des Maladies Rénales Rares, Hôpital Femme Mère Enfant et Université de Lyon, Lyon, France
    Nephrol Dial Transplant 25:611-6. 2010
    ..The pattern of malignancies that occur in the paediatric graft population is different from that in the general paediatric population and in the population of adult organ transplant recipients...
  22. ncbi request reprint 5% topical imiquimod tolerance in transplant recipients
    Amel Mebazaa
    Department of Dermatology, Saint Louis Hospital, Paris, France
    Dermatology 215:130-3. 2007
    ..Topical imiquimod is a new immunomodulator agent approved for genital warts, actinic keratosis (AK) or carcinoma, occurring in immunocompetent patients...
  23. ncbi request reprint Prognostic value of quantitative Kaposi sarcoma--associated herpesvirus load in posttransplantation Kaposi sarcoma
    Claire Pellet
    Laboratory of Pharmacology, Hopital Saint Louis, Paris, France
    J Infect Dis 186:110-3. 2002
    ..01). Thus, quantification of KSHV load in peripheral blood mononuclear cells could represent a useful tool for monitoring transplant recipients with KS...
  24. ncbi request reprint Selective expression of HLA-G in malignant and premalignant skin specimens in kidney transplant recipients
    Selim Aractingi
    Commissariat a l Energie Atomique, Hopital Saint Louis, Paris, France
    Int J Cancer 106:232-5. 2003
    ..Cytokines triggered in the course of organ transplantation include IL-10. This molecule may induce expression of HLA-G, which in turn may be implicated in tumor development in transplanted recipients...
  25. ncbi request reprint Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study
    Juan Carlos Martinez
    Mayo Medical School, Rochester, MN, USA
    Arch Dermatol 139:301-6. 2003
    ..To evaluate the demographic characteristics, clinical course, and outcome in organ transplant recipients with metastatic skin cancer...
  26. ncbi request reprint Skin carcinoma arising from donor cells in a kidney transplant recipient
    Selim Aractingi
    Unite de Dermatologie, Hopital Tenon, Paris, France
    Cancer Res 65:1755-60. 2005
    ..In conclusion, stem cells originating from a grafted kidney may migrate to the skin, differentiate, or fuse as keratinocytes that could, rarely, undergo cancer transformation...
  27. pmc Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy
    Jan N Bouwes Bavinck
    Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
    J Invest Dermatol 127:1647-56. 2007
    ....
  28. ncbi request reprint Merkel cell carcinoma in organ-transplant recipients: report of two cases with unusual histological features and literature review
    Jean Kanitakis
    Department of Dermatology EA 37 32, University Cl Bernard, France
    J Cutan Pathol 33:686-94. 2006
    ..Merkel cell carcinoma is an uncommon neuroendocrine skin tumor, of which 67 cases have been reported up till now, usually briefly, in organ transplant patients...
  29. ncbi request reprint Skin cancers in organ transplant recipients
    Jean Kanitakis
    J Am Acad Dermatol 54:1115. 2006
  30. ncbi request reprint Guidelines for the management of squamous cell carcinoma in organ transplant recipients
    Thomas Stasko
    Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    Dermatol Surg 30:642-50. 2004
    ..There are few published studies or reviews, which provide guidance to the clinician in the treatment of these patients...
  31. ncbi request reprint Complications of systemic retinoid therapy in organ transplant recipients with squamous cell carcinoma
    Juan Carlos Martinez
    Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Dermatol Surg 30:662-6. 2004
    ..Organ transplant recipients receiving immunosuppressive medications are at increased risk of cutaneous malignancies...
  32. ncbi request reprint Nontumoral dermatologic problems after liver transplantation
    Edmond Schmied
    Center for Skin Diseases, La Chaux de Fonds, Switzerland
    Liver Transpl 10:331-9. 2004
    ..Our intent is to provide an overview of the current knowledge regarding nontumoral dermatologic problems associated with liver transplantation by summarizing the available information from all documented case reports...
  33. ncbi request reprint Specialty clinics for the dermatologic care of solid-organ transplant recipients
    Leslie J Christenson
    Department of Dermatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Dermatol Surg 30:598-603. 2004
    ..Solid-organ transplant recipients constitute a complex patient population that experiences numerous and aggressive skin cancers. Proactive, comprehensive, ongoing, and effective dermatologic care of these patients is a necessity...
  34. ncbi request reprint Merkel cell carcinoma in immunocompetent and organ-transplant recipients do not harbor HPV
    Jean Kanitakis
    Eur J Dermatol 16:445-6. 2006
  35. ncbi request reprint [Graft versus host disease following liver transplantation. Favorable outcome after treatment with tacrolimus]
    Jerome Dumortier
    Gastroenterol Clin Biol 27:561-2. 2003